cartrophen Pentosan Polysulphate Sodium

Details

Cartrophen Vet has multiple pharmacological actions which affect the immune and tissue cell systems. These effects include:

Inhibition of enzymes which break down cartilage in addition to stimulating natural inhibitors of these destructive enzymes.
Improvement of the circulation of blood to the arthritic tissues, thus improving nutrition to the joint tissues.
Normalisation of the immune response by regulating the messenger molecules which control these processes.
Stimulation of the production of proteins which block damaging free radicals and antigens.

All this adds up to help repair and rejuvenate the damaged cartilage.

Cartrophen Vet is a revolutionary advance in the treatment for Osteoarthritis and musculoskeletal disease in dogs. It relieves pain and lameness, and increases the range of pain-free movement by treating the underlying disease processes - not just the symptoms. Cartrophen Vet is given as a weekly course for four weeks followed by a regular 3 month interim, and should be administered by your veterinary surgeon. (consult your veterinarian for instruction for sub-cutaneous administration)

Cartrophen Vet contains Pentosan Polysulphate Sodium which is a semi-synthetic polymer. It has anti-inflammatory properties which particularly affect the cartilage within synovial joints. Cartrophen modifies the metabolism of the cartilage and the production of the lubricating synovial fluid. Cartrophen influences the underlying disease processes occurring in arthritis, reducing pain and helping regenerate damaged joint components.

Cartrophen is not recommended for young, growing dogs or for pregnant bitches. Cartrophen is sometimes prescribed by vets for use in horses. (It is exactly the same product which is used in both species.)

Dosing Regiment:

All dogs treated with Cartrophen Vet will require a minimum of 1 full course per year. It is also recommended an OA check-up be performed at least every 6 months after OA has been diagnosed, essential to monitor progress and keep the disease under control and in order to determine the best time to repeat. Treatment is based on each individual patient and the objective is to prevent signs from recurring by stopping or slowing disease development.

Veterinary experience shows that clinical response generally lasts between 3 – 12 months and each patient should be assessed on an individual basis. While it will vary from case to case, from clinical experience, below are approximate recommended regimens.

Mild signs of OA – 1 course* every 12 months
Moderate signs of OA – 1 course* every 6 months (2 courses per 12 months)
Chronic and severe signs of OA – 1 course* every 4 months (3 courses per 12 months)
* course = administration every 5-7 days on four occasions.

More Information